Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?
Impact and interest:
Citation counts are sourced monthly from and citation databases.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||chronic myeloid leukaemia, clinical trials, dasatinib, imatinib, nilotinib|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500)|
|Divisions:||Past > QUT Faculties & Divisions > Faculty of Science and Technology
Past > Schools > Medical Sciences
Past > Schools > Pharmacy
|Deposited On:||19 Jul 2012 06:27|
|Last Modified:||03 Dec 2012 02:06|
Repository Staff Only: item control page